BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu D, Wang Y, Wu J, Zhang Z, Chen J, Xie M, Tang R, Cheng C, Chen L, Lin S, Luo X, Zheng J. MTIF2 impairs 5 fluorouracil-mediated immunogenic cell death in hepatocellular carcinoma in vivo: Molecular mechanisms and therapeutic significance. Pharmacol Res 2021;163:105265. [PMID: 33129983 DOI: 10.1016/j.phrs.2020.105265] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Wang W, Shen C, Zhao Y, Sun B, Bai N, Li X. Identification and validation of potential novel biomarkers to predict distant metastasis in differentiated thyroid cancer. Ann Transl Med 2021;9:1053. [PMID: 34422965 DOI: 10.21037/atm-21-383] [Reference Citation Analysis]
2 Yang H, Lei G, Sun F, Cheng J, Yan J, Zhang S, Yang P. Oncolytic Activity of a Chimeric Influenza A Virus Carrying a Human CTLA4 Antibody in Hepatocellular Carcinoma. Front Oncol 2022;12:875525. [PMID: 35494032 DOI: 10.3389/fonc.2022.875525] [Reference Citation Analysis]
3 Jia G, Wang Y, Lin C, Lai S, Dai H, Wang Z, Dai L, Su H, Song Y, Zhang N, Feng Y, Tang B. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2. J Exp Clin Cancer Res 2021;40:299. [PMID: 34551796 DOI: 10.1186/s13046-021-02090-7] [Reference Citation Analysis]